M28 Capital Management LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
M28 Capital Management LP disclosed 11 US equity positions worth $101.9m in its Q4 2024 13F filing. The largest position was WVE at 68.8% of the reported book, followed by TGTX and RCKT. Against the Q3 2024 filing, it opened 0 new positions, added to 1 and reduced 1 among the top 11 holdings.
What did M28 Capital Management LP own in Q4 2024? Top 11 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 68.8% | $70.1m | 5,664,548 | -8% | reduced |
| 2 | TGTX TG THERAPEUTICS INC | Healthcare | 4.8% | $4.9m | 161,600 | 0% | held |
| 3 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 4.8% | $4.8m | 385,680 | 0% | held |
| 4 | IVVD INVIVYD INC | Healthcare | 4.0% | $4.1m | 9,248,250 | 0% | held |
| 5 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 3.9% | $4.0m | 110,400 | 0% | held | |
| 6 | GUTS FRACTYL HEALTH INC | 3.8% | $3.8m | 1,856,117 | 0% | held | |
| 7 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.3% | $3.3m | 121,200 | 0% | held |
| 8 | PROQR THRAPEUTICS N V | 2.7% | $2.7m | 1,019,498 | 0% | held | |
| 9 | CRIS CURIS INC | 1.6% | $1.6m | 521,059 | 23% | added | |
| 10 | SLN SILENCE THERAPEUTICS PLC | 1.3% | $1.3m | 185,100 | 0% | held | |
| 11 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.2% | $1.3m | 67,400 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.